These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4429592)

  • 1. Glypentide: a new hypoglycaemic agent.
    Morell J
    Biochem Pharmacol; 1974 Oct; 23(20):2922-4. PubMed ID: 4429592
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacology of S 1702, a new highly effective oral antibiabetic drug with unusual properties. 1. Pharmacological and hypoglycaemic activity, studies in different animal species.
    Duhault J; Boulanger M; Tisserand F; Bergi L
    Arzneimittelforschung; 1972 Oct; 22(10):1682-5. PubMed ID: 4677056
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo(b)furan-m-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). I. Pharmacological studies on the hypoglycaemic effect.
    Jorgensen KD
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):216-26. PubMed ID: 402791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
    Tettenborn D
    Arzneimittelforschung; 1974 Mar; 24(0):409-18. PubMed ID: 4408138
    [No Abstract]   [Full Text] [Related]  

  • 5. Special pharmacology of the new sulfonylurea glimepiride.
    Geisen K
    Arzneimittelforschung; 1988 Aug; 38(8):1120-30. PubMed ID: 2904269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo (b) furan-7-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). II. Pharmacological studies on the mechanism of action.
    Jorgensen KD
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):227-33. PubMed ID: 190857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inotropic effect of tolbutamide and glipentide in isolated guinea pig atria (author's transl)].
    Sánchez-Casals MS; Morell-Mestre J
    Rev Esp Fisiol; 1974 Dec; 30(4):273-6. PubMed ID: 4456482
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].
    García-Rafanell J; Morell-Mestre J
    Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.
    Desnoyers P; Labaume J; Anstett M; Herrera M; Pesquet J; Sebastien J
    Arzneimittelforschung; 1972 Oct; 22(10):1691-5. PubMed ID: 4677058
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the mechanism of action of sulfonylurea compounds. Effect of glibornuride and insulin on blood sugar, plasma catecholamines and on the immunologically determinable insulin following blockade of adrenergic receptors].
    Cordes U; Beyer J; Sell G; Haupt E; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2164. PubMed ID: 4146790
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide.
    Artini D; Abbiati R; Orsini G; Parenti MA; Bloch K; Daturi S; Mandelli V
    Diabetologia; 1973 Sep; ():311-6. PubMed ID: 4204091
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological study of a new hypoglycaemic sulphonamide: glisoxepid (RP 22410).
    Loubatières A; Mariani MM; Ribes G; Alric R; Agot H
    Diabetologia; 1972 Feb; 8(1):29-36. PubMed ID: 4554823
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulinotropic action of a new sulfonylurea: gliclazide.
    Malaisse WJ; Leclercq-Meyer V
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):310-4. PubMed ID: 4626523
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progress in therapy for diabetes mellitus--insulin-secretion inducing oral hypoglycemic agents].
    Nagashima K; Inagaki N
    Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):737-41. PubMed ID: 19472523
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
    Poltorak VV; Gladkikh AI
    Probl Endokrinol (Mosk); 1985; 31(2):76-85. PubMed ID: 2859589
    [No Abstract]   [Full Text] [Related]  

  • 16. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
    Haupt E; Beyer J; Schöffling K
    Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
    [No Abstract]   [Full Text] [Related]  

  • 17. Dynamics of insulin release and microtubular-microfilamentous system. IV. Effect of colchicine upon sulphonylurea-induced insulin secretion.
    Van Obberghen E; Devis G; Somers G; Ravazzola M; Malaisse-Lagae F; Malaisse WJ
    Eur J Clin Invest; 1974 Oct; 4(5):307-12. PubMed ID: 4426330
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacologic profile of oral antidiabetic agents].
    Okubo M; Yamane K; Kohno N
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():310-6. PubMed ID: 12387011
    [No Abstract]   [Full Text] [Related]  

  • 19. [The blood-sugar depressing and betacytotrope effect of glibornurid in healthy and in gastric-resected persons (author's transl)].
    Grabner W; Matzkies F; Randerbrock V; Berg G
    Med Klin; 1973 Aug; 68(34):1101-5. PubMed ID: 4598149
    [No Abstract]   [Full Text] [Related]  

  • 20. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
    Marble A
    Drugs; 1971; 1(2):109-15. PubMed ID: 4999930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.